Corcept Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Aug 24 | SellUS$110,737 | Gary Robb | Individual | 3,101 | US$35.71 | |
06 Dec 23 | SellUS$37,301 | Gary Robb | Individual | 1,381 | US$27.01 |
Insider Trading Volume
Insider Buying: CORT insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 46,798 | 0.0448% |
General Public | 2,342,925 | 2.24% |
Hedge Funds | 6,912,571 | 6.62% |
Individual Insiders | 12,155,982 | 11.6% |
Institutions | 83,034,193 | 79.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
16,539,159 | US$751.4m | -1.71% | 0.01% | |||
9,553,706 | US$434.0m | -0.13% | 0.01% | |||
8,238,106 | US$374.3m | -0.78% | 14.32% | |||
6,912,571 | US$314.0m | -2.89% | 0.5% | |||
5,310,196 | US$241.2m | 0% | no data | |||
3,815,760 | US$173.4m | 0% | 4.19% | |||
3,499,370 | US$159.0m | -2.13% | 0.01% | |||
3,022,335 | US$137.3m | 6.72% | no data | |||
2,676,335 | US$121.6m | 4.23% | 0.02% | |||
2,411,362 | US$109.5m | 0% | 0.07% | |||
2,279,288 | US$103.5m | 5.63% | 0.01% | |||
2,215,093 | US$100.6m | -0.09% | no data | |||
1,583,899 | US$72.0m | -13.7% | 0.49% | |||
1,521,608 | US$69.1m | -17.3% | 0.06% | |||
1,483,422 | US$67.4m | -12.1% | 0.05% | |||
1,314,373 | US$59.7m | 8.09% | no data | |||
1,094,496 | US$49.7m | 28.5% | no data | |||
973,296 | US$44.2m | 4.27% | 0.01% | |||
949,143 | US$43.1m | -16.2% | 0.06% | |||
932,208 | US$42.4m | -3.24% | 0.01% | |||
870,834 | US$39.6m | 19.1% | 0.15% | |||
822,123 | US$37.3m | 8.53% | no data | |||
808,431 | US$36.7m | -21.9% | no data | |||
769,414 | US$35.0m | -25.5% | 0.12% | |||
716,056 | US$32.5m | 32.1% | 0.12% |